Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bevacizumab (avastin) (1 trial)
cetuximab (erbitux) (1 trial)
fluorouracil (efudex) (1 trial)
leac-102 (1 trial)
leucovorin (1 trial)
oxaliplatin (eloxatin) (1 trial)
Colorectal Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (6 total)